Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,129.60
(
-2.67%
)
News Focus
News Focus
Post# of 470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Number sleven

Send PM Follow Ignore
Followers 35
Posts 8849
Boards Moderated 1
Alias Born 04/04/2020

Number sleven

Re: Whalatane post# 250

Wednesday, 01/15/2025 12:51:57 PM

Wednesday, January 15, 2025 12:51:57 PM

Post# of 470
Kiwi, I agree. I also don't want to spend time in another biotech while it launches a drug. If the eypt p2 trial is successful, (it should be) I intend switching to ocular. They should get a nice bump on p3 outcome. I Will leave and go back for the eypt p3.
What are your thoughts?
Sleven,
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent OCUL News
More OCUL News